مصرف کانابیس، نوروبیولوژی، روانشناسی، و درمان ۲۰۲۳
Cannabis Use, Neurobiology, Psychology, and Treatment 2023

1. Cover

2. Front Matter

3. Table of Contents

4. Copyright

5. Dedication

6. Contributors

7. Preface

8. List of Illustrations

9. List of Tables

10. Chapter 1 : Metabolomics of the cannabis plant

11. Chapter 2 : Cannabis sativa roots: Chemical and pharmacological profile

12. Chapter 3 : Cannabis-related compounds in beverages and food

13. Chapter 4 : The impact of prenatal cannabis exposure: An overview

14. Chapter 5 : Cannabinoid genotoxicity and congenital anomalies: A convergent synthesis of European and USA data sets

15. Chapter 6 : Cannabis genotoxicity and cancer incidence: Highly concordant synthesis of European and USA datasets

16. Chapter 7 : Cannabis, cognitive impairment and car crash risk

17. Chapter 8 : Recreational cannabis use: French perspective of adverse effects

18. Chapter 9 : Acute and chronic impact of cannabis on human cognition

19. Chapter 10 : Polydrug users, use of cannabinoids and abuse potential: A focus on cannabidiol (CBD)

20. Chapter 11 : Cannabis stigmas: A narrative of features

21. Chapter 12 : Alterations of THC and CBD ratios and impact on cognition

22. Chapter 13 : When cannabis is used for medicinal purposes: A focus on back pain

23. Chapter 14 : Cannabis, cannabinoids, and receptor responses

24. Chapter 15 : Cannabidiol (CBD): Abuse and physical dependence potential

25. Chapter 16 : 4,5-Dihydro-1H-pyrazole/3,4-Diarylpyrazoline class of cannabinoid-1 (CB1R) receptor antagonists and their potential in medicinal applications

26. Chapter 17 : Neurobiology of the endocannabinoid system and relevance to cannabis use

27. Chapter 18 : Neurobiology of the kynurenine pathway and cannabis misuse: A new narrative

28. Chapter 19 : Central nervous system cancers and use of cannabis and related products: An updated narrative

29. Chapter 20 : The relationship between glutamate and resting-state connectivity in chronic cannabis users

30. Chapter 21 : Brain metabolic responses to cannabis use in people with multiple sclerosis: Insights from [18F]-FDG positron emission tomography and functional MRI

31. Chapter 22 : Genetic variation and acute responses to cannabis

32. Chapter 23 : Cell signaling of the CB1 cannabinoid receptor via β-arrestins, cannabinoid receptor interacting protein (CRIP1a) and other regulatory proteins

33. Chapter 24 : Impact of cannabis on memory: From in utero to adulthood

34. Chapter 25 : Age-related considerations in the use of cannabinoids: Focus on drug interactions, physiology, and drug effects

35. Chapter 26 : Cannabis, binge drinking, and memory in adolescents and young adults

36. Chapter 27 : The role of ΔFosB in the plasticity of the cannabinoid system

37. Chapter 28 : Functional profile of synthetic cannabinoid receptor agonists: Exploring cannabinoid and noncannabinoid targets

38. Chapter 29 : Linking the G-protein-coupled receptor 55 (GPR55) to the cannabinoid receptors (CB1 and CB2): A new narrative

39. Chapter 30 : Proteomic analysis of cannabinoids in human oligodendrocyte cells

40. Chapter 31 : Cannabinoids and endocannabinoid signaling at the basal forebrain cholinergic system

41. Chapter 32 : Cannabidiol (the major nonpsychotropic cannabinoid in the cannabis plant) and the PI3K/AKT signaling pathway in the CNS

42. Chapter 33 : Effects of cannabidiol and other phytocannabinoids on voltage- and ligand-gated ion channels

43. Chapter 34 : Cannabis, neurodevelopment, and the “two-hit” hypothesis

44. Chapter 35 : Impact of Δ9-tetrahydrocannabinol (THC) and synthetic “spice” cannabinoids on nicotine use and abuse

45. Chapter 36 : Synthetic cannabinoid receptor agonists compared to Δ9-tetrahydrocannabinol: Neurological effects and beyond

46. Chapter 37 : The DSM: 5 Criteria of cannabis use disorder: Methods and applications

47. Chapter 38 : Cannabis and clinical high risk for psychosis: Monitoring and smartphones

48. Chapter 39 : The impact of cannabis and cannabinoids on the skin

49. Chapter 40 : Cannabis consumption in reproductive function and teratogenicity

50. Chapter 41 : Phytocannabinoids have cytotoxic, antiproliferative, and antimigratory activities on cancer cells and cancer stem cells

51. Chapter 42 : Motivational interviewing for cannabis use disorders: A narrative review from research to practice

52. Chapter 43 : An overview of current pharmacologic interventions for management of cannabis withdrawal syndrome and the evidence for their use

53. Chapter 44 : Managing cannabinoid hyperemesis syndrome in pediatrics: A new narrative review

54. Chapter 45 : Gabapentinoids for the treatment of cannabis use disorder: A focus on human laboratory research

55. Chapter 46 : Treating psychosis in users of synthetic cannabinoids

56. Chapter 47 : Recommended resources for studying and investigating cannabis use, neurobiology, psychology, and treatments

57. Index

58. A